Literature DB >> 2953039

Down syndrome: sonographic sign for diagnosis in the second-trimester fetus.

B R Benacerraf, F D Frigoletto, D W Cramer.   

Abstract

In an expanded series of patients a sonographic sign was found to correlate well with the diagnosis of Down syndrome in second-trimester fetuses. The sign is characterized by soft-tissue thickening at the back of the fetal occiput. Sonographic evaluation for this sign was done in 2,121 consecutive fetuses between 15 and 20 gestational weeks of age at the time of genetic amniocentesis. The mothers were 35 years old or older or were otherwise at increased risk for fetal trisomies. Ten fetuses had Down syndrome by karyotype and four of these (40%) had thickened soft tissues (6 mm or more) at the back of the neck or occiput. When these data are combined with those in series previously reported by the authors, similarly collected consecutively, total second-trimester fetuses studied equals 3,825. Nine of the 21 (42%) Down syndrome fetuses by karyotype from this 3,825 had the positive sonographic sign described.

Entities:  

Mesh:

Year:  1987        PMID: 2953039     DOI: 10.1148/radiology.163.3.2953039

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.

Authors:  Alessandro Sacco; Claudio Coco; Lucia Mangiafico; Pietro Cignini; Alessandra Tiezzi; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2007-10

Review 2.  Fetal ultrasonography.

Authors:  S H Garmel; M E D'Alton
Journal:  West J Med       Date:  1993-09

3.  Nomograms of fetal nuchal fold thickness for early detection of Down syndrome.

Authors:  K Buckshee; K K Roy; I C Verma
Journal:  Indian J Pediatr       Date:  1993 Sep-Oct       Impact factor: 1.967

Review 4.  The role of ultrasound in the diagnosis of fetal genetic syndromes.

Authors:  Shayna N Conner; Ryan E Longman; Alison G Cahill
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2014-01-28       Impact factor: 5.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.